Concerning specific breast cancer driver genes/alterations reported by Nik-Zainal et al.24 we observed some small frequency differences (typically < 5–10%, when excluding MYC amplifications and TP53 mutations) between the two groups regarding copy number amplifications (Fig. 4b) and mutations (Fig. 4c). This evidence concerns the gene MYC and breast carcinoma.